Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel metal-free synthesis route for 3-aminobiphenyl compounds offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN103058880A reveals a novel Iodixanol intermediate synthesis route. Achieve >90% crude purity and simplified purification for reliable pharmaceutical supply chains.
Novel patent CN109928881A offers high-purity Cinacalcet Hydrochloride synthesis. Cost-effective, scalable, and environmentally friendly manufacturing solution for global supply chains.
Patent CN102060778A details a high-yield 81% synthesis route for Olmesartan intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103373916A introduces a two-step eco-friendly method for Ciprofibrate, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN114685298A reveals a green photocatalytic route for baclofen. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Novel patent CN110105233A enables high-yield iodination for contrast media intermediates. Reduces corrosion and impurities ensuring stable supply chain and cost efficiency.
Patent CN110156645B details a streamlined 2-step asymmetric synthesis for florfenicol intermediates, drastically cutting waste and costs while ensuring high optical purity for veterinary pharmaceutical manufacturing supply chains.
Patent CN103467528A details a streamlined Lobaplatin synthesis eliminating ion-exchange resins, offering cost reduction in pharmaceutical manufacturing and high-purity supply.
Novel patent CN113166040B details ion-exchange-free iomeprol production ensuring high purity and supply chain efficiency for global pharmaceutical manufacturers.
Novel patent CN105777780B enables high-yield thiazoline enol ester production. Enhances supply chain reliability and cost reduction in API manufacturing.
Patent CN111606827B reveals a safer DPPA-based route for Edoxaban intermediates, eliminating metal azides and reducing nitrosamine risks for reliable supply chains.
Patent CN109651478B reveals a high-yield six-step route for alclometasone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN109422675B details a high-yield, three-step synthesis of Morabemide, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN110204498B details a 5-step synthesis from 6-methyluracil, offering lower costs and greener solvents for scalable pharmaceutical intermediate production.
Novel patent CN111454217A details a green Rh-catalyzed route for Avapritinib intermediates, offering safer chiral induction and scalable manufacturing for global supply chains.
Novel patent CN120535519A offers improved yield and purity for Grapiprant. Reduces byproducts, ensures supply chain stability for veterinary pharmaceuticals.
Patent CN101445507B details a streamlined 3-step synthesis for praziquantel, offering significant cost reduction in pharmaceutical intermediates manufacturing and improved supply chain reliability.
Patent CN102126969A reveals a breakthrough configuration conversion method for Toremifene, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN108484500B reveals a mild iridium-catalyzed route for 1-trifluoroethyl isoquinoline intermediates, offering significant cost reduction and scalable manufacturing advantages.